(Bloomberg) -- AstraZeneca Plc rose after a report that a medical journal will release positive news on the coronavirus vaccine the company is developing with University of Oxford researchers.
Results from early tests of the vaccine in people will be published by The Lancet, perhaps Thursday, according to the report on the ITV.com website, which cited unnamed sources. AstraZeneca rose as much as 4% in London.
Drugmakers are racing to test vaccines in people to bring prevention against the coronavirus that's killed almost 600,000 people around the world as soon as possible. Moderna Inc. released results Tuesday from an early-stage test in 45 people that showed its vaccine raised levels of antibodies that fight the coronavirus, and said it's preparing for advanced trials.
There are about 160 coronavirus vaccines in various stages of development around the world, according to the World Health Organization. The Oxford vaccine has already begun final-stage testing. AstraZeneca has said it may begin delivering doses of the vaccine as early as September.
A representative for AstraZeneca declined to comment.
©2020 Bloomberg L.P.
Essential Business Intelligence, Continuous LIVE TV, Sharp Market Insights, Practical Personal Finance Advice and Latest Stories — On NDTV Profit.
